Glox Therapeutics Ltd

Glox Therapeutics Ltd. is developing precision antibiotics based on protein bacteriocins.

Biotechnology Research
Headquarters
Glasgow, United KingdomSource: RevenueBaseRetrieved October 13, 2026
Employee range
1 to 10Source: RevenueBaseRetrieved October 13, 2026
Published list appearances
2 supported appearances ↗Source: RevenueBase lists
The company at a glance

What does Glox Therapeutics Ltd do?

The antibiotics are intended to target Gram-negative antimicrobial-resistant pathogens with narrow-spectrum activity.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEWGlox Therapeutics Ltd listed #8 on Antimicrobial resistance solution providers, September 18, 2026Open the published source list.
Glox Therapeutics Ltd

#8 Antimicrobial resistance solution providers

Snapshot: September 18, 2026

Download SVG
View live list ↗

Company information

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →